http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1738938_PMID32428792

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID1738938_PMID32428792_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461562668_AID1738938_PMID32428792_VALUE10
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461514726_AID1738938_PMID32428792_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461561261_AID1738938_PMID32428792_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461553855_AID1738938_PMID32428792_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID404689686_AID1738938_PMID32428792_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461540917_AID1738938_PMID32428792_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461545429_AID1738938_PMID32428792_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461546387_AID1738938_PMID32428792_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID461562448_AID1738938_PMID32428792_VALUE9
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Antiproliferative activity against P-gp-positive/doxorubicin-resistant human K562/4 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461545429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID404689686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461553855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461562668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461562448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461540917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461561261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461546387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461514726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1738938

Total number of triples: 24.